Western University

GenEffects - Interventionseffekte auf das Bewegungs- und Sitzverhalten von Kindern und Jugendlichen aus einer Sex/Gender-Perspektive (2019) Schlund A, Vondung C, Bucksch J, Schulze C, Emmerling S, Reimers AK, Knapp G, et al. Conference contribution, Conference Contribution Interventions on children’s and adolescents’ physical activity and sedentary behaviour: protocol for a systematic review from a sex/gender perspective (2019) Demetriou Y, Vondung C, Bucksch J, Schlund A, Schulze C, Knapp G, Coen SE, et al. Journal article, Review article Status Report on Gender Equality in Energy Sector (2019) Baruah B, Chaianong A Other publication type Tree rings reveal globally coherent signature of cosmogenic radiocarbon events in 774 and 993 CE (2018) Buntgen U, Wacker L, Galvan JD, Arnold S, Arseneault D, Baillie M, Beer J, et al. Journal article, Original article Erratum to: Tree rings reveal globally coherent signature of cosmogenic radiocarbon events in 774 and 993 CE (Nature Communications, (2018), 9, 1, (3605), 10.1038/s41467-018-06036-0) (2018) Buntgen U, Wacker L, Galvan JD, Arnold S, Arseneault D, Baillie M, Beer J, et al. Journal article, Erratum Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018) Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al. Journal article Disorganized attachment in infancy: a review of the phenomenon and its implications for clinicians and policy-makers. (2017) Granqvist P, Sroufe LA, Dozier M, Hesse E, Steele M, Van Ijzendoorn M, Solomon J, et al. Journal article, Original article Mutations in KEOPS-complex genes cause nephritic syndrome with primary microcephaly (2017) Braun DA, Rao J, Mollet G, Schapiro D, Daugeron MC, Tan W, Gribouval O, et al. Journal article Bioenergy production and sustainable development: science base for policymaking remains limited (2017) Robledo-Abad C, Althaus HJ, Berndes G, Bolwig S, Corbera E, Creutzig F, Garcia-Ulloa J, et al. Journal article, Review article Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017) Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al. Journal article